ID: ALA4638502

Max Phase: Preclinical

Molecular Formula: C29H33N7O2

Molecular Weight: 511.63

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CN1CCc2nc(-c3cccc(OCC(=O)NC(C)(C)C)c3)nc(Nc3ccc(-c4cn[nH]c4)cc3)c2C1

Standard InChI:  InChI=1S/C29H33N7O2/c1-29(2,3)35-26(37)18-38-23-7-5-6-20(14-23)27-33-25-12-13-36(4)17-24(25)28(34-27)32-22-10-8-19(9-11-22)21-15-30-31-16-21/h5-11,14-16H,12-13,17-18H2,1-4H3,(H,30,31)(H,35,37)(H,32,33,34)

Standard InChI Key:  JRQYXWVDIBVRHN-UHFFFAOYSA-N

Associated Targets(Human)

Glucose transporter 14755 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Solute carrier family 2, facilitated glucose transporter member 3 465 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 511.63Molecular Weight (Monoisotopic): 511.2696AlogP: 4.56#Rotatable Bonds: 7
Polar Surface Area: 108.06Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.81CX Basic pKa: 6.94CX LogP: 4.01CX LogD: 3.88
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -1.60

References

1. Liu KG, Kim JI, Olszewski K, Barsotti AM, Morris K, Lamarque C, Yu X, Gaffney J, Feng XJ, Patel JP, Poyurovsky MV..  (2020)  Discovery and Optimization of Glucose Uptake Inhibitors.,  63  (10): [PMID:32282207] [10.1021/acs.jmedchem.9b02153]

Source